Lifestyle guru Martha Stewart on Tuesday launched a line of cannabis-infusedoil drops and soft-baked chews for dogs, months after the successful releaseof her cannabidiol (CBD) gummie treats for humans hit shelves in the UnitedStates.

Stewart is banking on a nearly one-year partnership with Canada’s CanopyGrowth Corp , the world’s top pot producer by market value, and now wants toreach pet owners and tap into a meteoric rise in demand for pot-basedproducts.

Last year, stay at home orders to stem the spread of COVID-19 limited people’sentertainment options and fueled stress and anxiety. Cannabis-infused edibles,like gummies and chocolates, and beverages were among the most highly-soughtcannabis products.

CBD, a non-psychoactive compound derived mainly from hemp, is being researchedfor various medical applications and is widely advertised to have relaxingproperties.

Stewart wants to bring those benefits to dogs with CBD oil drops and soft-baked chews, which she claims can help with mental and physical well-being,reduce stress and maintain joint health and movement.

“My dogs are not only my companions, but they are part of my family, and Iprioritize their emotional and physical well-being as I do my own,” Stewartsaid in a statement.

“Just as CBD can support human wellness, it’s been shown to improve thequality of life for pets as well,” she added.

Stewart’s line will include soft chews marketed under three differentcategories – wellness, calm and mobility – ranging between $19.99 and $22.99depending on the formula and size of the dog.

The products will be available starting Tuesday on Canopy’s e-commercewebsites and on Franchise Group Inc’s The Vitamin Shoppe website next month.

The market for pet CBD products is expected to reach sales of about $400million in 2027 from just $37.4 million last year, according to a reportreleased by Grand View Research Inc in August. (Reporting by Shariq Khan inBengaluru; Editing by Bernard Orr)

Previous Treaties Committee to review new CITES listings

Next PharmAust anti-cancer drug trials meeting targets, calling more dogs!

Leave a Reply

Your email address will not be published.